东亚肠道微生物组及其在瘤学中的作用:叙事性综述
Evelyn Yi Ting Wong1, Jonathan Wei Jie Lee2, Jeremy Fung Yen Lim3
1Division of Medical Oncology, National Cancer Centre Singapore; AMILI Pte Ltd, Singapore.
Singapore medical journal
|June 20, 2023
概括
肠道微生物组显著影响癌症免疫疗法的有效性. 本综述强调了东亚微生物组研究及其在癌症生物学和治疗中的临床应用.
科学领域:
- 在瘤学瘤学.
- 微生物学 微生物学
- 免疫学 免疫学 免疫学
背景情况:
- 肠道微生物组在宿主新陈代谢,免疫和病原体防御中发挥着关键作用.
- 诸如饮食和便微生物群移植等干预措施可以调节肠道微生物群.
- 特定的肠道微生物已经显示出增强癌症免疫疗法的潜力,特别是免疫检查点抑制剂.
研究的目的:
- 审查癌症生物学中微生物组科学的当前状态.
- 专注于东亚微生物组在癌症免疫治疗中的作用和应用.
- 提供关于微生物组研究在瘤学中的临床应用的概述.
主要方法:
- 文献综述侧重于共微生物组研究.
- 强调与东亚人口有关的研究.
- 分析癌症生物学和免疫治疗中的临床应用.
主要成果:
- 瘤微生物组领域正在迅速发展.
- 肠道微生物群影响营养代谢,免疫调节和病原体耐药性.
- 有证据支持使用特定的微生物组来改善癌症免疫治疗结果.
结论:
- 肠道微生物组是癌症生物学和免疫治疗的组成部分.
- 东亚微生物组研究为onco-microbiome应用提供了独特的见解.
- 对微生物组操纵的进一步研究有望为新的癌症疗法提供希望.
相关概念视频
The Tumor Microenvironment
6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Cancers Originate from Somatic Mutations in a Single Cell
12.1K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.1K
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K


